We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Global Infusion Pump Market to Surpass USD 850 Million by 2028

By HospiMedica International staff writers
Posted on 21 Apr 2022
Print article
Image: Global infusion pump market is projected to register a CAGR of 4.0% during 2022-2028 (Photo courtesy of Pexels)
Image: Global infusion pump market is projected to register a CAGR of 4.0% during 2022-2028 (Photo courtesy of Pexels)

Infusion pumps are used to deliver medication in many cases, such as cancer and diabetic conditions, to keep drug levels in the bloodstream stable. These pumps have several advantages over manual fluid administration, including the ability to administer fluids in very small doses and at precise programmed rates. Chemotherapy must be delivered to cancer patients on a continuous basis, which can be accomplished with the help of a pump. Insulin pumps are becoming increasingly popular in the treatment of Type 1 diabetes. As a result, the global infusion pump market will be driven by rising incidence of chronic diseases, rapid growth of the geriatric population who require home care, rising demand for ambulatory infusion pumps, and growing volume of surgical procedures performed around the world.

These are the latest findings of Valuates Reports (Bangalore, India), a market research firm.

The global infusion pump market was valued at about USD 627 million in 2021 and is projected to grow at a CAGR of 4% during 2022-2028 to surpass USD 852 million by 2028. Growing demand for ambulatory infusion pumps in-home care settings, as well as an increase in chronic disease incidence, is expected to drive the growth of the infusion pump market. Infusion pumps for ambulatory use are designed to be portable or wearable. The high incidence and prevalence of chronic diseases, as well as rising healthcare expenditure, primarily on hospitalization, have increased the demand for home healthcare in recent years.

In addition, increasing research and development (R&D) activities to launch home infusion systems are expected to drive the growth of the infusion pump market. Rising costs of hospital-based infusion therapies have prompted an increase in R&D efforts to create home-based infusion products. For instance, the rising demand for long-term care, preferably in-home care settings, has been due to an increase in the patient population with diabetes, cancer, and neurological disorders. Furthermore, the growing geriatric population, which requires long-term care therapies, is driving new product development for home infusion therapies.

Furthermore, the use of robotics in surgical treatments and the introduction of technology in minimally invasive procedures are the keys to the future of surgical procedures, which will lead to an increase in sales of syringe and infusion pumps. This, in turn, is expected to drive the growth of the infusion pump market. Automated syringe pumps are commonly used in hospitals and clinics to improve the efficiency of drug infusion in the patient's body. Moreover, to increase their market share, the players in the global infusion pumps market are actively launching new products targeted at specific disease treatment procedures, and undertaking geographic expansions and collaborations.

Based on type, accessories/consumables is expected to be the most lucrative segment in the infusion pump market due to the frequent use and purchase of accessories/consumables for infusion therapy. Based on application, the oncology segment is expected to gain significant traction due to the rising prevalence of various cancers and the increasing number of new product launches in this area. Chemotherapy must be delivered to cancer patients on a continuous basis, which can be accomplished with the use of infusion pumps.

Geographically, North America is expected to be the world’s most lucrative market for infusion pumps due to the rapid adoption of technologically advanced products by patients and physicians, both for regular treatment of chronic disease conditions, in the region. In North America, several chronic diseases are becoming more prevalent, and the rapid adoption of home healthcare infusion pump therapies is also fueling the growth of the infusion pump market in the region.

Related Links:
Valuates Reports 

Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Mechanical Baby Scale
seca 725

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.